Yuta Lee is the Founder and CEO of Accelerated Bio, a pioneering biotech company at the forefront of regenerative medicine. With a bold mission to extend human healthspan and reverse biological aging, for more than 20 years, Yuta has led the commercialization of human Trophoblast Stem Cells (hTSCs), the earliest ethically sourced cells from the embryonic stage to unlock transformative therapies for age-related decline.

Under Yuta’s leadership, Accelerated Bio is redefining the future of cell and gene therapy through its proprietary use of the hTSC secretome, a powerful exosome-based platform shown to systemically downregulate inflammation and combat cellular senescence. In a recent breakthrough collaboration with the National Institute on Aging (NIH), Accelerated Bio demonstrated that hTSC-derived exosomes significantly reduce Senescence-Associated Secretory Phenotypes (SASPs), a major driver of aging and chronic disease. These results mark a critical step toward developing preventive therapeutics that target aging at its root - cellular dysfunction.

Yuta’s passion lies in democratizing access to cutting-edge regenerative technologies and making longevity science both scalable and accessible. With a clear vision, he is accelerating the next generation of therapeutics that go beyond symptom management to restore youthful biological function and bring the promise of extended healthspan closer to reality.

Previous to Accelerated Bio, Yuta worked in risk management for insurance giants such as AIG, Chubb, and ULLICO. Yuta holds dual B.A. degrees in Economics and Law from the University of California, Berkeley, and earned his Executive MBA from the China Europe International Business School (CEIBS) in Shanghai, where he was honored as the Outstanding Graduate of the Year in 2009.

As a thought leader in longevity innovation, Yuta Lee is not only building a company, he is helping shape a new paradigm in prevention and healthspan.